Thiomersal (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Thiomersal" in English language version.

refsWebsite

Global rank English rank

27nih.gov

4^th place

21doi.org

2^nd place

12web.archive.org

1^st place

8semanticscholar.org

11^th place

8^th place

4cdc.gov

218^th place

212^th place

4fda.gov

447^th place

338^th place

3who.int

195^th place

302^nd place

2theguardian.com

12^th place

11^th place

2worldcat.org

5^th place

1sigmaaldrich.com

924^th place

2,352^nd place

1medlineplus.gov

1,581^st place

1,299^th place

1nap.edu

2,128^th place

1,553^rd place

1patents.google.com

1,182^nd place

725^th place

1npr.org

92^nd place

72^nd place

1aappublications.org

3,763^rd place

3,602^nd place

1merck-chemicals.com

low place

1ehponline.org

low place

1tandfonline.com

507^th place

429^th place

1cbc.ca

115^th place

82^nd place

1aap.org

low place

1nytimes.com

7^th place

aap.org

publications.aap.org

Schering S (23 July 2025). "HHS approves flu vaccines without thimerosal, manufacturers expect no disruptions". American Academy of Pediatrics. Retrieved 24 July 2025.{{cite web}}: CS1 maint: url-status (link)

aappublications.org

Wyckoff AS (22 January 2013). "Global ban on mercury grants exception to thimerosal-containing vaccines". AAP News. American Academy of Pediatrics. Archived from the original on 13 January 2016. Retrieved 24 August 2019.

cbc.ca

"U.S. vaccine panel rejects flu shots with a specific preservative, despite safety data". CBC News. Associated Press. 27 June 2025. Archived from the original on 27 June 2025. Retrieved 2 July 2025.

cdc.gov

"Thimerosal and Vaccines | Vaccine Safety | CDC". Centers for Disease Control and Prevention. 25 August 2020. Retrieved 4 May 2023.
"Vaccines Do Not Cause Autism". cdc.gov. Retrieved 29 November 2015.
Centers for Disease Control and Prevention (CDC) (July 1999). "Thimerosal in vaccines: a joint statement of the American Academy of Pediatrics and the Public Health Service". MMWR. Morbidity and Mortality Weekly Report. 48 (26): 563–565. PMID 10418806.
Centers for Disease Control (8 February 2008). "Mercury and vaccines (thimerosal)". Archived from the original on 18 April 2018. Retrieved 19 May 2009.

doi.org

Melnick JG, Yurkerwich K, Buccella D, Sattler W, Parkin G (July 2008). "Molecular structures of thimerosal (Merthiolate) and other arylthiolate mercury alkyl compounds". Inorganic Chemistry. 47 (14): 6421–6426. doi:10.1021/ic8005426. PMID 18533648.
Sharpe MA, Livingston AD, Baskin DS (2012). "Thimerosal-Derived Ethylmercury Is a Mitochondrial Toxin in Human Astrocytes: Possible Role of Fenton Chemistry in the Oxidation and Breakage of mtDNA". Journal of Toxicology. 2012: 373678. doi:10.1155/2012/373678. PMC 3395253. PMID 22811707. ...widely used in medical products, including as a preservative in vaccines, immunoglobulin preparations, skin test antigens, antivenins, ophthalmic and nasal products, and tattoo inks...
Immunization Safety Review Committee, Board on Health Promotion and Disease Prevention, Institute of Medicine (2004). Immunization Safety Review: Vaccines and Autism. Washington, DC: The National Academies Press. doi:10.17226/10997. ISBN 978-0-309-09237-1. PMID 20669467.
Doja A, Roberts W (November 2006). "Immunizations and autism: a review of the literature". The Canadian Journal of Neurological Sciences. Le Journal Canadien des Sciences Neurologiques. 33 (4): 341–346. doi:10.1017/s031716710000528x. PMID 17168158.
Baker JP (February 2008). "Mercury, vaccines, and autism: one controversy, three histories". American Journal of Public Health. 98 (2): 244–253. doi:10.2105/AJPH.2007.113159. PMC 2376879. PMID 18172138.
Waldo JH (March 1931). "Some new water-soluble organo-mercury compounds". Journal of the American Chemical Society. 53 (3): 992–996. doi:10.1021/ja01354a022.
Bigham M, Copes R (2005). "Thiomersal in vaccines: balancing the risk of adverse effects with the risk of vaccine-preventable disease". Drug Safety. 28 (2): 89–101. doi:10.2165/00002018-200528020-00001. PMID 15691220. S2CID 11570020.
Clarkson TW (February 2002). "The three modern faces of mercury". Environmental Health Perspectives. 110 (Suppl 1): 11–23. doi:10.1289/ehp.02110s111. PMC 1241144. PMID 11834460. Archived from the original on 6 September 2008.
Magos L (2003). "Neurotoxic character of thimerosal and the allometric extrapolation of adult clearance half-time to infants". Journal of Applied Toxicology. 23 (4): 263–269. doi:10.1002/jat.918. PMID 12884410. S2CID 20703489.
Clarkson TW, Magos L (September 2006). "The toxicology of mercury and its chemical compounds". Critical Reviews in Toxicology. 36 (8): 609–662. doi:10.1080/10408440600845619. PMID 16973445. S2CID 37652857.
Clarkson TW, Vyas JB, Ballatori N (October 2007). "Mechanisms of mercury disposition in the body". American Journal of Industrial Medicine. 50 (10): 757–764. doi:10.1002/ajim.20476. PMID 17477364.
Dotterud LK, Smith-Sivertsen T (January 2007). "Allergic contact sensitization in the general adult population: a population-based study from Northern Norway". Contact Dermatitis. 56 (1): 10–15. doi:10.1111/j.1600-0536.2007.00980.x. PMID 17177703. S2CID 25765635.
Uter W, Ludwig A, Balda BR, Schnuch A, Pfahlberg A, Schäfer T, et al. (June 2004). "The prevalence of contact allergy differed between population-based and clinic-based data". Journal of Clinical Epidemiology. 57 (6): 627–632. doi:10.1016/j.jclinepi.2003.04.002. PMID 15246132.
Aberer W (January 1991). "Vaccination despite thimerosal sensitivity". Contact Dermatitis. 24 (1): 6–10. doi:10.1111/j.1600-0536.1991.tb01621.x. PMID 2044374. S2CID 43264826.
Thyssen JP, Linneberg A, Menné T, Johansen JD (November 2007). "The epidemiology of contact allergy in the general population--prevalence and main findings". Contact Dermatitis. 57 (5): 287–299. doi:10.1111/j.1600-0536.2007.01220.x. PMID 17937743. S2CID 44890665.
Czarnobilska E, Obtulowicz K, Dyga W, Spiewak R (March 2011). "The most important contact sensitizers in Polish children and adolescents with atopy and chronic recurrent eczema as detected with the extended European Baseline Series". Pediatric Allergy and Immunology. 22 (2): 252–256. doi:10.1111/j.1399-3038.2010.01075.x. PMID 20969635. S2CID 22195669.
"AAP and PHS Urge Reduction of Mercury in Vaccines". Public Health Reports. 114 (5): 394–395. 1999. doi:10.1093/phr/114.5.394 (inactive 12 July 2025). PMC 1308509.{{cite journal}}: CS1 maint: DOI inactive as of July 2025 (link)
DeStefano F (December 2007). "Vaccines and autism: evidence does not support a causal association". Clinical Pharmacology and Therapeutics. 82 (6): 756–759. doi:10.1038/sj.clpt.6100407. PMID 17928818. S2CID 12872702.
Sugarman SD (September 2007). "Cases in vaccine court--legal battles over vaccines and autism". The New England Journal of Medicine. 357 (13): 1275–1277. doi:10.1056/NEJMp078168. PMID 17898095.
Offit PA (September 2007). "Thimerosal and vaccines--a cautionary tale". The New England Journal of Medicine. 357 (13): 1278–1279. doi:10.1056/NEJMp078187. PMID 17898096.
Autism cases in vaccine court:
- Sugarman SD (September 2007). "Cases in vaccine court--legal battles over vaccines and autism". The New England Journal of Medicine. 357 (13): 1275–1277. doi:10.1056/NEJMp078168. PMID 17898095.

ehponline.org

Clarkson TW (February 2002). "The three modern faces of mercury". Environmental Health Perspectives. 110 (Suppl 1): 11–23. doi:10.1289/ehp.02110s111. PMC 1241144. PMID 11834460. Archived from the original on 6 September 2008.

fda.gov

"Thimerosal and vaccines". Center for Biologics Evaluation and Research, U.S. Food and Drug Administration. 2 January 2018. Retrieved 9 April 2023.
"Thimerosal in Vaccines: Frequently Asked Questions". Food and Drug Administration. Archived from the original on 31 December 2008. Retrieved 9 March 2008.
"Mercury in plasma-derived products". U.S. Food and Drug Administration. 9 September 2004. Archived from the original on 29 September 2007. Retrieved 1 October 2007.
"Thimerosal in vaccines: frequently asked questions (FAQs)". Center for Biologics Evaluation and Research, U.S. Food and Drug Administration. 7 June 2007. Archived from the original on 3 December 2001. Retrieved 22 July 2008.

medlineplus.gov

"Merthiolate poisoning: MedlinePlus Medical Encyclopedia". medlineplus.gov. Retrieved 8 December 2023.

merck-chemicals.com

"Safety data sheet, Thiomersal Ph Eur, BP, USP" (PDF). Merck. 12 June 2005. Archived from the original (PDF) on 15 September 2009. Retrieved 1 January 2010.

nap.edu

Immunization Safety Review Committee, Board on Health Promotion and Disease Prevention, Institute of Medicine (2004). Immunization Safety Review: Vaccines and Autism. Washington, DC: The National Academies Press. doi:10.17226/10997. ISBN 978-0-309-09237-1. PMID 20669467.

nih.gov

pubmed.ncbi.nlm.nih.gov

Melnick JG, Yurkerwich K, Buccella D, Sattler W, Parkin G (July 2008). "Molecular structures of thimerosal (Merthiolate) and other arylthiolate mercury alkyl compounds". Inorganic Chemistry. 47 (14): 6421–6426. doi:10.1021/ic8005426. PMID 18533648.
Sharpe MA, Livingston AD, Baskin DS (2012). "Thimerosal-Derived Ethylmercury Is a Mitochondrial Toxin in Human Astrocytes: Possible Role of Fenton Chemistry in the Oxidation and Breakage of mtDNA". Journal of Toxicology. 2012: 373678. doi:10.1155/2012/373678. PMC 3395253. PMID 22811707. ...widely used in medical products, including as a preservative in vaccines, immunoglobulin preparations, skin test antigens, antivenins, ophthalmic and nasal products, and tattoo inks...
Immunization Safety Review Committee, Board on Health Promotion and Disease Prevention, Institute of Medicine (2004). Immunization Safety Review: Vaccines and Autism. Washington, DC: The National Academies Press. doi:10.17226/10997. ISBN 978-0-309-09237-1. PMID 20669467.
Doja A, Roberts W (November 2006). "Immunizations and autism: a review of the literature". The Canadian Journal of Neurological Sciences. Le Journal Canadien des Sciences Neurologiques. 33 (4): 341–346. doi:10.1017/s031716710000528x. PMID 17168158.
Gołoś A, Lutyńska A (2015). "Thiomersal-containing vaccines - a review of the current state of knowledge". Przeglad Epidemiologiczny. 69 (1): 59–64, 157–61. PMID 25862449.
Baker JP (February 2008). "Mercury, vaccines, and autism: one controversy, three histories". American Journal of Public Health. 98 (2): 244–253. doi:10.2105/AJPH.2007.113159. PMC 2376879. PMID 18172138.
Bigham M, Copes R (2005). "Thiomersal in vaccines: balancing the risk of adverse effects with the risk of vaccine-preventable disease". Drug Safety. 28 (2): 89–101. doi:10.2165/00002018-200528020-00001. PMID 15691220. S2CID 11570020.
Clarkson TW (February 2002). "The three modern faces of mercury". Environmental Health Perspectives. 110 (Suppl 1): 11–23. doi:10.1289/ehp.02110s111. PMC 1241144. PMID 11834460. Archived from the original on 6 September 2008.
Magos L (2003). "Neurotoxic character of thimerosal and the allometric extrapolation of adult clearance half-time to infants". Journal of Applied Toxicology. 23 (4): 263–269. doi:10.1002/jat.918. PMID 12884410. S2CID 20703489.
Clarkson TW, Magos L (September 2006). "The toxicology of mercury and its chemical compounds". Critical Reviews in Toxicology. 36 (8): 609–662. doi:10.1080/10408440600845619. PMID 16973445. S2CID 37652857.
Clarkson TW, Vyas JB, Ballatori N (October 2007). "Mechanisms of mercury disposition in the body". American Journal of Industrial Medicine. 50 (10): 757–764. doi:10.1002/ajim.20476. PMID 17477364.
Dotterud LK, Smith-Sivertsen T (January 2007). "Allergic contact sensitization in the general adult population: a population-based study from Northern Norway". Contact Dermatitis. 56 (1): 10–15. doi:10.1111/j.1600-0536.2007.00980.x. PMID 17177703. S2CID 25765635.
Uter W, Ludwig A, Balda BR, Schnuch A, Pfahlberg A, Schäfer T, et al. (June 2004). "The prevalence of contact allergy differed between population-based and clinic-based data". Journal of Clinical Epidemiology. 57 (6): 627–632. doi:10.1016/j.jclinepi.2003.04.002. PMID 15246132.
Aberer W (January 1991). "Vaccination despite thimerosal sensitivity". Contact Dermatitis. 24 (1): 6–10. doi:10.1111/j.1600-0536.1991.tb01621.x. PMID 2044374. S2CID 43264826.
Thyssen JP, Linneberg A, Menné T, Johansen JD (November 2007). "The epidemiology of contact allergy in the general population--prevalence and main findings". Contact Dermatitis. 57 (5): 287–299. doi:10.1111/j.1600-0536.2007.01220.x. PMID 17937743. S2CID 44890665.
Czarnobilska E, Obtulowicz K, Dyga W, Spiewak R (March 2011). "The most important contact sensitizers in Polish children and adolescents with atopy and chronic recurrent eczema as detected with the extended European Baseline Series". Pediatric Allergy and Immunology. 22 (2): 252–256. doi:10.1111/j.1399-3038.2010.01075.x. PMID 20969635. S2CID 22195669.
Centers for Disease Control and Prevention (CDC) (July 1999). "Thimerosal in vaccines: a joint statement of the American Academy of Pediatrics and the Public Health Service". MMWR. Morbidity and Mortality Weekly Report. 48 (26): 563–565. PMID 10418806.
DeStefano F (December 2007). "Vaccines and autism: evidence does not support a causal association". Clinical Pharmacology and Therapeutics. 82 (6): 756–759. doi:10.1038/sj.clpt.6100407. PMID 17928818. S2CID 12872702.
Sugarman SD (September 2007). "Cases in vaccine court--legal battles over vaccines and autism". The New England Journal of Medicine. 357 (13): 1275–1277. doi:10.1056/NEJMp078168. PMID 17898095.
Offit PA (September 2007). "Thimerosal and vaccines--a cautionary tale". The New England Journal of Medicine. 357 (13): 1278–1279. doi:10.1056/NEJMp078187. PMID 17898096.
Autism cases in vaccine court:
- Sugarman SD (September 2007). "Cases in vaccine court--legal battles over vaccines and autism". The New England Journal of Medicine. 357 (13): 1275–1277. doi:10.1056/NEJMp078168. PMID 17898095.
ncbi.nlm.nih.gov
- Sharpe MA, Livingston AD, Baskin DS (2012). "Thimerosal-Derived Ethylmercury Is a Mitochondrial Toxin in Human Astrocytes: Possible Role of Fenton Chemistry in the Oxidation and Breakage of mtDNA". Journal of Toxicology. 2012: 373678. doi:10.1155/2012/373678. PMC 3395253. PMID 22811707. ...widely used in medical products, including as a preservative in vaccines, immunoglobulin preparations, skin test antigens, antivenins, ophthalmic and nasal products, and tattoo inks...
- Baker JP (February 2008). "Mercury, vaccines, and autism: one controversy, three histories". American Journal of Public Health. 98 (2): 244–253. doi:10.2105/AJPH.2007.113159. PMC 2376879. PMID 18172138.
- Clarkson TW (February 2002). "The three modern faces of mercury". Environmental Health Perspectives. 110 (Suppl 1): 11–23. doi:10.1289/ehp.02110s111. PMC 1241144. PMID 11834460. Archived from the original on 6 September 2008.
- Institute of Medicine (US) Immunization Safety Review Committee (2001). "Thimerosal-Containing Vaccines and Neurodevelopmental Disorders". In Stratton K, Gable A, McCormick MC (eds.). Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders. Washington (DC): National Academies Press (US).
- "AAP and PHS Urge Reduction of Mercury in Vaccines". Public Health Reports. 114 (5): 394–395. 1999. doi:10.1093/phr/114.5.394 (inactive 12 July 2025). PMC 1308509.{{cite journal}}: CS1 maint: DOI inactive as of July 2025 (link)
pubchem.ncbi.nlm.nih.gov
- Chambers M. "ChemIDplus – 54-64-8 – RTKIYNMVFMVABJ-UHFFFAOYSA-L – Thimerosal [USP:JAN] – Similar structures search, synonyms, formulas, resource links, and other chemical information". chem.sis.nlm.nih.gov. Retrieved 3 April 2018.

npr.org

Hamilton J (17 December 2012). "Doctors Argue Against Proposed Ban on Vaccine Preservative". NPR. Retrieved 25 February 2013.

nytimes.com

Harris G, O'Connor A (25 June 2005). "On autism's cause, it's parents vs. research". New York Times. Retrieved 11 March 2016.

patents.google.com

U.S. patent 1,672,615 "Alkyl mercuric sulphur compound and process of producing it".

semanticscholar.org

api.semanticscholar.org

Bigham M, Copes R (2005). "Thiomersal in vaccines: balancing the risk of adverse effects with the risk of vaccine-preventable disease". Drug Safety. 28 (2): 89–101. doi:10.2165/00002018-200528020-00001. PMID 15691220. S2CID 11570020.
Magos L (2003). "Neurotoxic character of thimerosal and the allometric extrapolation of adult clearance half-time to infants". Journal of Applied Toxicology. 23 (4): 263–269. doi:10.1002/jat.918. PMID 12884410. S2CID 20703489.
Clarkson TW, Magos L (September 2006). "The toxicology of mercury and its chemical compounds". Critical Reviews in Toxicology. 36 (8): 609–662. doi:10.1080/10408440600845619. PMID 16973445. S2CID 37652857.
Dotterud LK, Smith-Sivertsen T (January 2007). "Allergic contact sensitization in the general adult population: a population-based study from Northern Norway". Contact Dermatitis. 56 (1): 10–15. doi:10.1111/j.1600-0536.2007.00980.x. PMID 17177703. S2CID 25765635.
Aberer W (January 1991). "Vaccination despite thimerosal sensitivity". Contact Dermatitis. 24 (1): 6–10. doi:10.1111/j.1600-0536.1991.tb01621.x. PMID 2044374. S2CID 43264826.
Thyssen JP, Linneberg A, Menné T, Johansen JD (November 2007). "The epidemiology of contact allergy in the general population--prevalence and main findings". Contact Dermatitis. 57 (5): 287–299. doi:10.1111/j.1600-0536.2007.01220.x. PMID 17937743. S2CID 44890665.
Czarnobilska E, Obtulowicz K, Dyga W, Spiewak R (March 2011). "The most important contact sensitizers in Polish children and adolescents with atopy and chronic recurrent eczema as detected with the extended European Baseline Series". Pediatric Allergy and Immunology. 22 (2): 252–256. doi:10.1111/j.1399-3038.2010.01075.x. PMID 20969635. S2CID 22195669.
DeStefano F (December 2007). "Vaccines and autism: evidence does not support a causal association". Clinical Pharmacology and Therapeutics. 82 (6): 756–759. doi:10.1038/sj.clpt.6100407. PMID 17928818. S2CID 12872702.

sigmaaldrich.com

"Thimerosal, 54-64-8, High-Purity, T5125, Sigma-Aldrich". www.sigmaaldrich.com.

tandfonline.com

Clarkson TW, Magos L (September 2006). "The toxicology of mercury and its chemical compounds". Critical Reviews in Toxicology. 36 (8): 609–662. doi:10.1080/10408440600845619. PMID 16973445. S2CID 37652857.

theguardian.com

Glenza J (26 June 2025). "RFK Jr's new vaccine panel votes against preservative in flu shots in shock move". The Guardian. ISSN 0261-3077. Retrieved 26 June 2025.
Glenza J (23 July 2025). "RFK Jr to remove preservative thimerosal from all US vaccines". The Guardian. ISSN 0261-3077. Archived from the original on 23 July 2025. Retrieved 24 July 2025.

web.archive.org

"Thimerosal in Vaccines: Frequently Asked Questions". Food and Drug Administration. Archived from the original on 31 December 2008. Retrieved 9 March 2008.
"Mercury in plasma-derived products". U.S. Food and Drug Administration. 9 September 2004. Archived from the original on 29 September 2007. Retrieved 1 October 2007.
Global Advisory Committee on Vaccine Safety (14 July 2006). "Thiomersal and vaccines". World Health Organization. Archived from the original on 20 August 2003. Retrieved 20 November 2007.
Wyckoff AS (22 January 2013). "Global ban on mercury grants exception to thimerosal-containing vaccines". AAP News. American Academy of Pediatrics. Archived from the original on 13 January 2016. Retrieved 24 August 2019.
"Safety data sheet, Thiomersal Ph Eur, BP, USP" (PDF). Merck. 12 June 2005. Archived from the original (PDF) on 15 September 2009. Retrieved 1 January 2010.
Clarkson TW (February 2002). "The three modern faces of mercury". Environmental Health Perspectives. 110 (Suppl 1): 11–23. doi:10.1289/ehp.02110s111. PMC 1241144. PMID 11834460. Archived from the original on 6 September 2008.
"U.S. vaccine panel rejects flu shots with a specific preservative, despite safety data". CBC News. Associated Press. 27 June 2025. Archived from the original on 27 June 2025. Retrieved 2 July 2025.
Glenza J (23 July 2025). "RFK Jr to remove preservative thimerosal from all US vaccines". The Guardian. ISSN 0261-3077. Archived from the original on 23 July 2025. Retrieved 24 July 2025.
"Thimerosal in vaccines: frequently asked questions (FAQs)". Center for Biologics Evaluation and Research, U.S. Food and Drug Administration. 7 June 2007. Archived from the original on 3 December 2001. Retrieved 22 July 2008.
World Health Organization (2006). "Thiomersal and vaccines: questions and answers". Archived from the original on 12 October 2003. Retrieved 19 May 2009.
WHO. "Statement on thiomersal". www.who.int. Archived from the original on 29 October 2012. Retrieved 3 April 2018.
Centers for Disease Control (8 February 2008). "Mercury and vaccines (thimerosal)". Archived from the original on 18 April 2018. Retrieved 19 May 2009.

who.int

Global Advisory Committee on Vaccine Safety (14 July 2006). "Thiomersal and vaccines". World Health Organization. Archived from the original on 20 August 2003. Retrieved 20 November 2007.
World Health Organization (2006). "Thiomersal and vaccines: questions and answers". Archived from the original on 12 October 2003. Retrieved 19 May 2009.
WHO. "Statement on thiomersal". www.who.int. Archived from the original on 29 October 2012. Retrieved 3 April 2018.

worldcat.org

search.worldcat.org

Glenza J (26 June 2025). "RFK Jr's new vaccine panel votes against preservative in flu shots in shock move". The Guardian. ISSN 0261-3077. Retrieved 26 June 2025.
Glenza J (23 July 2025). "RFK Jr to remove preservative thimerosal from all US vaccines". The Guardian. ISSN 0261-3077. Archived from the original on 23 July 2025. Retrieved 24 July 2025.

Thiomersal (English Wikipedia)

aap.org

publications.aap.org

aappublications.org

cbc.ca

cdc.gov

doi.org

ehponline.org

fda.gov

medlineplus.gov

merck-chemicals.com

nap.edu

nih.gov

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

pubchem.ncbi.nlm.nih.gov

npr.org

nytimes.com

patents.google.com

semanticscholar.org

api.semanticscholar.org

sigmaaldrich.com

tandfonline.com

theguardian.com

web.archive.org

who.int

worldcat.org

search.worldcat.org